F. E. Rivera-Sánchez, C. Moreno-Licea, R. Mellado-Orellana, S. González-Santiesteban, and R. de la Peña-López, “Pneumonitis, a common adverse event of cyclin-dependent kinase 4/6 inhibitors: a case report”, Int J Sci Rep, vol. 8, no. 3, pp. 78–80, Feb. 2022.